News
Following the successful MAPS study, MDMA-assisted therapy moves closer to becoming approved by the US FDA
Hi, what are you looking for?
Mugglehead Investment Magazine
All posts tagged "MAPS"
Industry update
Thursday, April 27, four experts including MAPS founder Rick Doblin and former US drug policy advisor Kevin Sabet debate the merits of psychedelic reform
Industry update
US researchers seek DEA to permit potent pot production after long-awaited FDA-backed study shows weak weed ineffective at treating PTSD
Medical and Pharmaceutical
Numinus Wellness goes public on the prediction that regulation is coming
